TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Chan, B. A. AU - Hughes, B. G. PY - 2015 DA - 2015// TI - Targeted therapy for non-small cell lung cancer: current standards and the promise of the future JO - Transl Lung Cancer Res VL - 4 ID - Chan2015 ER - TY - JOUR AU - Langevin, S. M. AU - Kratzke, R. A. AU - Kelsey, K. T. PY - 2015 DA - 2015// TI - Epigenetics of lung cancer JO - Transl Res VL - 165 UR - https://doi.org/10.1016/j.trsl.2014.03.001 DO - 10.1016/j.trsl.2014.03.001 ID - Langevin2015 ER - TY - JOUR AU - Ansari, J. AU - Shackelford, R. E. AU - El-Osta, H. PY - 2015 DA - 2015// TI - Epigenetics in non-small cell lung cancer: from basics to therapeutics JO - Transl Lung Cancer Res VL - 5 UR - https://doi.org/10.21037/tlcr.2016.02.02 DO - 10.21037/tlcr.2016.02.02 ID - Ansari2015 ER - TY - JOUR AU - Juergens, R. A. AU - Wrangle, J. AU - Vendetti, F. P. AU - Murphy, S. C. AU - Zhao, M. AU - Coleman, B. PY - 2011 DA - 2011// TI - Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0214 DO - 10.1158/2159-8290.CD-11-0214 ID - Juergens2011 ER - TY - JOUR AU - Ramalingam, S. S. AU - Maitland, M. L. AU - Frankel, P. AU - Argiris, A. E. AU - Koczywas, M. AU - Gitlitz, B. PY - 2010 DA - 2010// TI - Carboplatin and paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.9094 DO - 10.1200/JCO.2009.24.9094 ID - Ramalingam2010 ER - TY - JOUR AU - Witta, S. E. AU - Jotte, R. M. AU - Konduri, K. AU - Neubauer, M. A. AU - Spira, A. I. AU - Ruxer, R. L. PY - 2012 DA - 2012// TI - Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.9411 DO - 10.1200/JCO.2011.38.9411 ID - Witta2012 ER - TY - JOUR AU - Han, J. Y. AU - Lee, S. H. AU - Lee, G. K. AU - Yun, T. AU - Lee, Y. J. AU - Hwang, K. H. PY - 2015 DA - 2015// TI - Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer JO - Cancer Chemother Pharmacol VL - 75 UR - https://doi.org/10.1007/s00280-014-2664-9 DO - 10.1007/s00280-014-2664-9 ID - Han2015 ER - TY - JOUR AU - Reguart, N. AU - Rosell, R. AU - Cardenal, F. AU - Cardona, A. F. AU - Isla, D. AU - Palmero, R. PY - 2014 DA - 2014// TI - Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression JO - Lung Cancer VL - 84 UR - https://doi.org/10.1016/j.lungcan.2014.02.011 DO - 10.1016/j.lungcan.2014.02.011 ID - Reguart2014 ER - TY - JOUR AU - Hoang, T. AU - Campbell, T. C. AU - Zhang, C. AU - Kim, K. AU - Kolesar, J. M. AU - Oettel, K. R. PY - 2014 DA - 2014// TI - Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study JO - Investig New Drugs VL - 321 UR - https://doi.org/10.1007/s10637-013-9980-5 DO - 10.1007/s10637-013-9980-5 ID - Hoang2014 ER - TY - JOUR AU - Millward, M. AU - Price, T. AU - Townsend, A. AU - Sweeney, C. AU - Spencer, A. AU - Sukumaran, S. PY - 2012 DA - 2012// TI - Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination JO - Investig New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-011-9766-6 DO - 10.1007/s10637-011-9766-6 ID - Millward2012 ER - TY - JOUR AU - Wrangle, J. AU - Wang, W. AU - Koch, A. AU - Easwaran, H. AU - Mohammad, H. P. AU - Vendetti, F. PY - 2013 DA - 2013// TI - Alterations of immune response of non-small cell lung cancer with azacytidine JO - Oncotarget VL - 11 UR - https://doi.org/10.18632/oncotarget.1542 DO - 10.18632/oncotarget.1542 ID - Wrangle2013 ER - TY - JOUR AU - Kim, H. AU - Kwon, Y. M. AU - Kim, J. S. AU - Lee, H. AU - Park, J. H. AU - Shim, Y. M. PY - 2004 DA - 2004// TI - Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.10.077 DO - 10.1200/JCO.2004.10.077 ID - Kim2004 ER - TY - CHAP AU - Edge, S. B. AU - Byrd, D. R. AU - Compton, C. C. AU - Fritz, A. G. AU - Greene, F. L. AU - Troth, A. PY - 2010 DA - 2010// TI - American joint committee on cancer BT - AJCC cancer staging manual PB - Springer CY - New York ID - Edge2010 ER - TY - JOUR AU - Pidsley, R. AU - Y Wong, C. C. AU - Volta, M. AU - Lunnon, K. AU - Mill, J. AU - Schalkwyk, L. C. PY - 2013 DA - 2013// TI - A data-driven approach to preprocessing Illumina 450K methylation array data JO - BMC Genomics VL - 14 UR - https://doi.org/10.1186/1471-2164-14-293 DO - 10.1186/1471-2164-14-293 ID - Pidsley2013 ER - TY - JOUR AU - Hubers, A. J. AU - Prinsen, C. F. AU - Sozzi, G. AU - Witte, B. I. AU - Thunnissen, E. PY - 2013 DA - 2013// TI - Molecular sputum analysis for the diagnosis of lung cancer JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.393 DO - 10.1038/bjc.2013.393 ID - Hubers2013 ER - TY - JOUR AU - Soda, M. AU - Isobe, K. AU - Inoue, A. AU - Maemondo, M. AU - Oizumi, S. AU - Fujita, Y. AU - Gemma, A. PY - 2012 DA - 2012// TI - A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2947 DO - 10.1158/1078-0432.CCR-11-2947 ID - Soda2012 ER - TY - JOUR AU - Guo, M. AU - House, M. G. AU - Hooker, C. AU - Han, Y. AU - Heath, E. AU - Gabrielson, E. AU - Yang, S. C. PY - 2004 DA - 2004// TI - Promoter hypermethylation of resected bronchial margins: a field defect of changes? JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0763 DO - 10.1158/1078-0432.CCR-03-0763 ID - Guo2004 ER - TY - JOUR AU - Belinsky, S. A. AU - Palmisano, W. A. AU - Gilliland, F. D. AU - Crooks, L. A. AU - Divine, K. K. AU - Winters, S. A. PY - 2002 DA - 2002// TI - Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers JO - Cancer Res VL - 62 ID - Belinsky2002 ER - TY - JOUR AU - Kelly, M. M. AU - Efthimiadis, A. AU - Hargreave, F. E. PY - 2001 DA - 2001// TI - Induced sputum: selection method JO - Methods Mol Med VL - 56 ID - Kelly2001 ER - TY - JOUR AU - Hwang, J. A. AU - Lee, B. B. AU - Kim, Y. AU - Hong, S. H. AU - Kim, Y. H. AU - Han, J. PY - 2015 DA - 2015// TI - HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer JO - Mol Carcinog VL - 54 UR - https://doi.org/10.1002/mc.22180 DO - 10.1002/mc.22180 ID - Hwang2015 ER - TY - JOUR AU - Son, J. W. AU - Jeong, K. J. AU - Jean, W. S. AU - Park, S. Y. AU - Jheon, S. AU - Cho, H. M. PY - 2011 DA - 2011// TI - Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients JO - Cancer Lett VL - 311 UR - https://doi.org/10.1016/j.canlet.2011.06.021 DO - 10.1016/j.canlet.2011.06.021 ID - Son2011 ER - TY - JOUR AU - Yu, S. L. AU - Lee, D. C. AU - Sohn, H. A. AU - Lee, S. Y. AU - Jeon, H. S. AU - Lee, J. H. AU - Park, C. G. PY - 2016 DA - 2016// TI - Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells JO - Mol Carcinog VL - 55 UR - https://doi.org/10.1002/mc.22439 DO - 10.1002/mc.22439 ID - Yu2016 ER - TY - JOUR AU - Yin, D. AU - Jia, Y. AU - Yu, Y. AU - Brock, M. V. AU - Herman, J. G. AU - Han, C. PY - 2012 DA - 2012// TI - SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer JO - Discov Med VL - 14 ID - Yin2012 ER - TY - JOUR AU - DY, F. AU - Wang, Z. M. AU - Li-Chen AU - Wang, B. L. AU - Shen, Z. Z. AU - Huang, W. PY - 2010 DA - 2010// TI - Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer JO - Breast Cancer Res Treat VL - 119 UR - https://doi.org/10.1007/s10549-009-0339-8 DO - 10.1007/s10549-009-0339-8 ID - DY2010 ER - TY - JOUR AU - Li, Y. AU - Lv, Z. AU - He, G. AU - Wang, J. AU - Zhang, X. AU - Lu, G. PY - 2015 DA - 2015// TI - The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3603 DO - 10.18632/oncotarget.3603 ID - Li2015 ER - TY - JOUR AU - Kuo, I. Y. AU - CC, W. AU - Chang, J. M. AU - Huang, Y. L. AU - Lin, C. H. AU - Yan, J. J. PY - 2014 DA - 2014// TI - Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression JO - Int J Cancer VL - 135 UR - https://doi.org/10.1002/ijc.28695 DO - 10.1002/ijc.28695 ID - Kuo2014 ER - TY - JOUR AU - Tseng, R. C. AU - Huang, W. R. AU - Lin, S. F. AU - PC, W. AU - Hsu, H. S. AU - Wang, Y. C. PY - 2014 DA - 2014// TI - HBP1 promoter hypermethylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC JO - J Cell Mol Med VL - 18 UR - https://doi.org/10.1111/jcmm.12318 DO - 10.1111/jcmm.12318 ID - Tseng2014 ER - TY - JOUR AU - Coghlin, C. L. AU - Smith, L. J. AU - Bakar, S. AU - Stewart, K. N. AU - Devereux, G. S. AU - Nicolson, M. C. PY - 2010 DA - 2010// TI - Quantitative analysis of tumor in bronchial biopsy specimens JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181ca12c4 DO - 10.1097/JTO.0b013e3181ca12c4 ID - Coghlin2010 ER - TY - JOUR AU - Guyon, I. AU - Weston, J. AU - Barnhill, S. AU - Vapnik, V. PY - 2002 DA - 2002// TI - Gene selection for cancer classification using support vector machine JO - Mach Learn VL - 46 UR - https://doi.org/10.1023/A:1012487302797 DO - 10.1023/A:1012487302797 ID - Guyon2002 ER - TY - JOUR AU - Breiman, L. PY - 2001 DA - 2001// TI - Random forests JO - Mach Learn VL - 45 UR - https://doi.org/10.1023/A:1010933404324 DO - 10.1023/A:1010933404324 ID - Breiman2001 ER - TY - JOUR AU - Dayhoff, J. E. AU - DeLeo, J. M. PY - 2001 DA - 2001// TI - Artificial neural networks: opening the black box JO - Cancer VL - 91 UR - https://doi.org/3.0.CO;2-L DO - 3.0.CO;2-L ID - Dayhoff2001 ER -